SCOPUS 정보 검색 플랫폼

Volumn 8, Issue 3, 2002, Pages 856-862

Structural identification and biological activity of 7-methyl-10,11-ethylenedioxy-20(S)-camptothecin, a photodegradant of lurtotecan

(9) Loos, Walter J a Verweij, Jaap a Kehrer, Diederik F S a De Bruijn, Peter a Nooter, Kees a Stoter, Gerrit a Sparreboom, Alex a De Groot, Franciscus M H b Hamilton, Marta c

a ERASMUS MEDICAL CENTER (Netherlands)

b RADBOUD UNIVERSITY NIJMEGEN (Netherlands)

c OSI PHARMACEUTICALS INC (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; 7 METHYL 10,11 ETHYLENEDIOXY CAMPTOTHECIN; CAMPTOTHECIN DERIVATIVE; LURTOTECAN; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CONCENTRATION RESPONSE; CYTOTOXICITY; DRUG DEGRADATION; DRUG PURIFICATION; DRUG STORAGE; DRUG STRUCTURE; HUMAN; HUMAN CELL; LIVER MICROSOME; PHOTODEGRADATION; PHOTOLYSIS; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

ADULT; ANTINEOPLASTIC AGENTS; CAMPTOTHECIN; CELL DIVISION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; LIGHT; MALE; MIDDLE AGED; MOLECULAR STRUCTURE; TUMOR CELLS, CULTURED;

EID: 0036301382 PISSN: 10780432 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (4)

References (20)

1
- 0030940635
- Structure-activity relation in camptothecin antitumor drugs: Why a detailed molecular characterisation of their lactone and carboxylate forms by Raman and SERS spectroscopies?
- (1997) Biochim. Biophys. Acta , vol.1334 , pp. 349-360
- Chourpa, I.¹ Beljebbar, A.² Sockalingum, G.D.³ Riou, J.F.⁴ Manfait, M.⁵

2
- 0033926690
- Determination of camptothecin analogs in biological matrices by highperformance liquid chromatography
- (2000) Anticancer Drugs , vol.11 , pp. 315-324
- Loos, W.J.¹ De Bruijn, P.² Verweij, J.³ Sparreboom, A.⁴

3
- 0035098297
- Modulation of camptothecin analogues in the treatment of cancer: A review
- (2001) Anticancer Drugs , vol.12 , pp. 89-105
- Kehrer, D.F.S.¹ Soepenberg, O.² Loos, W.J.³ Verweij, J.⁴ Sparreboom, A.⁵

4
- 0033865075
- DX-8951f, a hexacyclic camptothecin analog, on a daily-times-five schedule: A Phase I and pharmacokinetic study in patients with advanced solid malignancies
- (2000) J. Clin. Oncol. , vol.18 , pp. 3151-3163
- Rowinsky, E.K.¹ Johnson, T.R.² Geyer, C.E.³ Hammond, L.A.⁴ Eckhardt, S.G.⁵ Drengler, R.⁶ Smetzer, L.⁷ Coyle, J.⁸ Rizzo, J.⁹ Schwartz, G.¹⁰ Tolcher, A.¹¹ Von Hoff, D.D.¹² De Jager, R.L.¹³

5
- 0028911408
- In vivo antitumor activity of two new seven-substituted water-soluble camptothecin analogues
- (1995) Cancer Res. , vol.55 , pp. 603-609
- Emerson, D.L.¹ Besterman, J.M.² Brown, H.R.³ Evans, M.G.⁴ Leitner, P.P.⁵ Luzzio, M.J.⁶ Shaffer, J.E.⁷ Sternbach, D.D.⁸ Uchling, D.⁹ Vuong, A.¹⁰

6
- 0029928849
- Pharmacological study of the new topoisomerase I inhibitor GI147211, using a daily x 5 intravenous administration
- (1996) Br. J. Cancer , vol.73 , pp. 744-750
- Gerrits, C.J.¹ Creemers, G.J.² Schellens, J.H.³ Wissel, P.⁴ Planting, A.S.⁵ Kunka, R.⁶ Selinger, K.⁷ Boer-Dennert, M.⁸ Marijnen, Y.⁹ Harteveld, M.¹⁰ Verweij, J.¹¹

7
- 15644373056
- Phase I and pharmacokinetic study of GI147211, a water-soluble camptothecin analogue, administered for five consecutive days every three weeks
- (1998) Clin. Cancer Res. , vol.4 , pp. 595-604
- Eckhardt, S.G.¹ Baker, S.D.² Eckardt, J.R.³ Burke, T.G.⁴ Warner, D.L.⁵ Kuhn, J.G.⁶ Rodriguez, G.⁷ Fields, S.⁸ Thurman, A.⁹ Smith, L.¹⁰ Rothenberg, M.L.¹¹ White, L.¹² Wissel, P.¹³ Kunka, R.¹⁴ Depee, S.¹⁵ Little-Field, D.¹⁶ Burris, H.A.¹⁷ Von Hoff, D.D.¹⁸ Rowinsky, E.K.¹⁹

8
- 0031789627
- A Phase I clinical and pharmacokinetic study of the new topoisomerase inhibitor GI147211 given as a 72-h continuous infusion
- (1998) Br. J. Cancer , vol.78 , pp. 1329-1336
- Paz-Ares, L.¹ Kunka, R.² DeMaria, D.³ Cassidy, J.⁴ Alden, M.⁵ Beranek, P.⁶ Kaye, S.⁷ Littlefield, D.⁸ Reilly, D.⁹ Depee, S.¹⁰ Wissel, P.¹¹ Twelves, C.¹² O'Dwyer, P.¹³

9
- 0033911713
- Antitumor efficacy, pharmacokinetics, and biodistribution of NX 211: A low-clearance liposomal formulation of lurtotecan
- (2000) Clin. Cancer Res. , vol.6 , pp. 2903-2912
- Emerson, D.L.¹ Bendele, R.² Brown, E.³ Chiang, S.⁴ Desjardins, J.P.⁵ Dihel, L.C.⁶ Gill, S.C.⁷ Hamilton, M.⁸ LeRay, J.D.⁹ Moon-McDermott, L.¹⁰ Moynihan, K.¹¹ Richardson, F.C.¹² Tomkinson, B.¹³ Luzzio, M.J.¹⁴ Baccanari, D.¹⁵

10
- 0036499054
- Pharmacologic study of liposomal lurtotecan: Urinary excretion predicts hematologic toxicity
- (2002) J. Clin. Oncol.
- Kehrer, D.F.S.¹ Bos, A.M.² Verweij, J.³ Groen, H.J.⁴ Loos, W.J.⁵ Sparreboom, A.⁶ De Jonge, M.J.A.⁷ Hamilton, M.⁸ Cameron, T.⁹ De Vries, E.G.E.¹⁰

11
- 0033984541
- Liposomal lurtotecan (NX211): Determination of total drug levels in human plasma and urine by reversed-phase high-performance liquid chromatography
- (2000) J. Chromatogr. B Biomed. Sci. Appl. , vol.738 , pp. 155-163
- Loos, W.J.¹ Kehrer, D.² Brouwer, E.³ Verweij, J.⁴ De Bruijn, P.⁵ Hamilton, M.⁶ Gill, S.⁷ Nooter, K.⁸ Stoter, G.⁹ Sparreboom, A.¹⁰

12
- 0025341331
- New colorimetric cytotoxicity assay for anticancer-drug screening
- (1990) J. Natl. Cancer Inst. , vol.82 , pp. 1107-1112
- Skehan, P.¹ Storeng, R.² Scudiero, D.³ Monks, A.⁴ McMahon, J.⁵ Vistica, D.⁶ Warren, J.T.⁷ Bokesch, H.⁸ Kenney, S.⁹ Boyd, M.R.¹⁰

13
- 0031785256
- Irinotecan (CPT-11) metabolism and disposition in cancer patients
- (1998) Clin. Cancer Res. , vol.4 , pp. 2747-2754
- Sparreboom, A.¹ De Jonge, M.J.² De Bruijn, P.³ Brouwer, E.⁴ Nooter, K.⁵ Loos, W.J.⁶ Van Alphen, R.J.⁷ Mathijssen, R.H.⁸ Stoter, G.⁹ Verweij, J.¹⁰

14
- 0028998076
- Synthesis and antitumor activity of novel water soluble derivatives of camptothecin as specific inhibitors of topoisomerase I
- (1995) J. Med. Chem. , vol.38 , pp. 395-401
- Luzzio, M.J.¹ Besterman, J.M.² Emerson, D.L.³ Evans, M.G.⁴ Lackey, K.⁵ Leitner, P.L.⁶ McIntyre, G.⁷ Morton, B.⁸ Myers, P.L.⁹ Peel, M.¹⁰

15
- 0033952901
- 7- and 10-substituted camptothecins: Dependence of topoisomerase I-DNA cleavable complex formation and stability
- (2000) Mol. Pharmacol. , vol.57 , pp. 243-251
- Vladu, B.¹ Woynarowski, J.M.² Manikumar, G.³ Wani, M.C.⁴ Wall, M.E.⁵ Von Hoff, D.D.⁶ Wadkins, R.M.⁷

16
- 0028225471
- Comparison of topoisomerase I inhibition, DNA damage, and cytotoxicity of camptothecin derivatives presently in clinical trials
- (1994) J. Natl. Cancer Inst. , vol.86 , pp. 836-842
- Tanizawa, A.¹ Fujimori, A.² Fujimori, Y.³ Pommier, Y.⁴

17
- 0024232266
- Study of doxorubicin photodegradation in plasma, urine and cell culture medium by HPLC
- (1988) Biomed. Chromatogr. , vol.2 , pp. 242-244
- Le Bot, M.A.¹ Riche, C.² Guedes, Y.³ Kernaleguen, D.⁴ Simon, S.⁵ Begue, J.M.⁶ Berthou, F.⁷

18
- 0031441796
- Photodegradation of irinotecan (CPT-11) in aqueous solutions: Identification of fluorescent products and influence of solution composition
- (1997) J. Pharm. Sci. , vol.86 , pp. 1410-1416
- Dodds, H.M.¹ Craik, D.J.² Rivory, L.P.³

19
- 17744409784
- The detection of photodegradation products of irinotecan (CPT. 11, Campto, Camptosar), in clinical studies, using high-performance liquid chromatography/atmospheric pressure chemical ionisation/mass spectrometry
- (1998) J. Pharm. Biomed. Anal. , vol.17 , pp. 785-792
- Dodds, H.M.¹ Robert, J.² Rivory, L.P.³

20
- 0032546536
- Modulation in kinetics of lactone ring hydrolysis of camptothecins upon interaction with topoisomerase I cleavage sites on DNA
- (1998) Biochemistry , vol.37 , pp. 7284-7291
- Chourpa, I.¹ Riou, J.F.² Millot, J.M.³ Pommier, Y.⁴ Manfait, M.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.